{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,31]],"date-time":"2026-07-31T20:26:22Z","timestamp":1785529582039,"version":"3.56.0"},"reference-count":135,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T00:00:00Z","timestamp":1768176000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>The adrenal glands play an essential role in maintaining homeostasis through the secretion of steroid hormones. Among these, aldosterone, a mineralocorticoid produced in the zona glomerulosa (ZG) of the adrenal cortex, regulates fluid balance and blood pressure. This review summarizes the current knowledge of adrenal anatomy, aldosterone biosynthesis and regulation, and the pathophysiology and genetic landscape of primary aldosteronism (PA), a common form of secondary hypertension. Advances in next-generation sequencing have enabled the discovery of novel somatic and germline mutations underlying PA, elucidating their roles in abnormal aldosterone production and adrenal cell proliferation. Understanding the molecular basis of aldosterone dysregulation provides critical insights into PA subtypes, informing the development of improved diagnostic and therapeutic strategies.<\/jats:p>","DOI":"10.3389\/fendo.2025.1736534","type":"journal-article","created":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:44:37Z","timestamp":1768196677000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["The adrenal gland and primary aldosteronism: anatomy, steroidogenesis, regulation, and genetic insights"],"prefix":"10.3389","volume":"16","author":[{"given":"Kha Chin","family":"Long","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena Aisha","family":"Azizan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,1,12]]},"reference":[{"key":"B1","volume-title":"Opuscula anatomica","author":"Eustachi","year":"1564"},{"key":"B2","first-page":"1855","volume-title":"On the constitutional and local effects of disease of the supra-renal capsules","author":"Addison","year":"1855"},{"key":"B3","volume-title":"Recherches exp\u00e9rimentales sur la physiologie et la pathologie des capsules surr\u00e9nales","author":"Brown-S\u00e9quard","year":"1856"},{"key":"B4","volume-title":"Williams Textbook of Endocrinology","author":"Newell-Price","year":"2019"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.15998","article-title":"Effect of dietary sodium modulation on pig adrenal steroidogenesis and transcriptome profiles","volume":"76","author":"Vohra","year":"2020","journal-title":"Hypertension"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/en.2013-1999","article-title":"Sodium deficiency regulates rat adrenal zona glomerulosa gene expression","volume":"155","author":"Nishimoto","year":"2014","journal-title":"Endocrinology"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/endo.135.1.8013381","article-title":"A novel cell layer without corticosteroid-synthesizing enzymes in rat adrenal cortex: histochemical detection and possible physiological role","volume":"135","author":"Mitani","year":"1994","journal-title":"Endocrinology"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/jemt.10331","article-title":"Adrenocortical zonation and ACTH","volume":"61","author":"Vinson","year":"2003","journal-title":"Microsc Res Tech"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2016.00238","article-title":"Functional zonation of the adult mammalian adrenal cortex","volume":"10","author":"Vinson","year":"2016","journal-title":"Front Neurosci"},{"key":"B10","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1139\/o83-088","article-title":"Regulation by ACTH of steroid hormone biosynthesis in the adrenal cortex","volume":"61","author":"Simpson","year":"1983","journal-title":"Can J Biochem Cell Biol"},{"key":"B11","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-1-4939-2895-8_5","article-title":"Regulation of glucose homeostasis by glucocorticoids","volume":"872","author":"Kuo","year":"2015","journal-title":"Adv Exp Med Biol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.3181\/00379727-92-22416","article-title":"Secretion of aldosterone by the zona glomerulosa of rat adrenal glands incubated in vitro","volume":"92","author":"Giroud","year":"1956","journal-title":"Proc Soc Exp Biol Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2004.01.004","article-title":"Steroid hormones: relevance and measurement in the clinical laboratory","volume":"24","author":"Holst","year":"2004","journal-title":"Clin Lab Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2022.770375","article-title":"Aldosterone-regulated sodium transport and blood pressure","volume":"13","author":"Tsilosani","year":"2022","journal-title":"Front Physiol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1152\/ajprenal.1994.266.1.F76","article-title":"Minealocorticoid receptors and 11 beta-steroid dehydrogenase activity in renal principal and intercalated cells","volume":"266","author":"N\u00e1ray-Fejes-T\u00f3th","year":"1994","journal-title":"Am J Physiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1210\/er.2005-0004","article-title":"The nongenomic actions of aldosterone","volume":"26","author":"Funder","year":"2005","journal-title":"Endocr Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1210\/er.2018-00262","article-title":"Steroid metabolome analysis in disorders of adrenal steroid biosynthesis and metabolism","volume":"40","author":"Storbeck","year":"2019","journal-title":"Endocr Rev"},{"key":"B18","doi-asserted-by":"publisher","first-page":"77","DOI":"10.20945\/2359-3997000000438","article-title":"Classic and current concepts in adrenal steroidogenesis: a reappraisal","volume":"66","author":"Kater","year":"2022","journal-title":"Arch Endocrinol Metab"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)46930-X","article-title":"The purification, cloning, and expression of a novel luteinizing hormone-induced mitochondrial protein in MA-10 mouse Leydig tumor cells. Characterization of the steroidogenic acute regulatory protein (StAR)","volume":"269","author":"Clark","year":"1994","journal-title":"J Biol Chem"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/S0303-7207(99)00051-9","article-title":"Adrenal zonation: clues from 11beta-hydroxylase and aldosterone synthase","volume":"151","author":"Rainey","year":"1999","journal-title":"Mol Cell Endocrinol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(19)30030-4","article-title":"Characterization of two genes encoding human steroid 11 beta-hydroxylase (P-450(11) beta)","volume":"264","author":"Mornet","year":"1989","journal-title":"J Biol Chem"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1080\/07435809609043735","article-title":"Calcium regulates human CYP11B2 transcription","volume":"22","author":"Clyne","year":"1996","journal-title":"Endocr Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/mend.11.5.9920","article-title":"Angiotensin II and potassium regulate human CYP11B2 transcription through common cis-elements","volume":"11","author":"Clyne","year":"1997","journal-title":"Mol Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1007\/s00424-012-1126-7","article-title":"Regulation of renin secretion by renal juxtaglomerular cells","volume":"465","author":"Friis","year":"2013","journal-title":"Pflugers Arch"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1210\/er.2007-0030","article-title":"A lifetime of aldosterone excess: long-term consequences of altered regulation of aldosterone production for cardiovascular function","volume":"29","author":"Connell","year":"2008","journal-title":"Endocrine Rev"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2011.07.034","article-title":"Acute and chronic regulation of aldosterone production","volume":"350","author":"Hattangady","year":"2012","journal-title":"Mol Cell Endocrinol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-41-1-153","article-title":"Potassim-aldosterone-renin interrelationships","volume":"41","author":"Himathongkam","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2003.10.046","article-title":"Glomerulosa cell\u2013a unique sensor of extracellular K+ concentration","volume":"217","author":"Sp\u00e4t","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"B29","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1152\/physrev.00030.2003","article-title":"Control of aldosterone secretion: a model for convergence in cellular signaling pathways","volume":"84","author":"Sp\u00e4t","year":"2004","journal-title":"Physiol Rev"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(18)50666-9","article-title":"Adrenocorticotropin action in isolated adrenal cells. The intermediate role of cyclic AMP in stimulation of corticosterone synthesis","volume":"254","author":"Sala","year":"1979","journal-title":"J Biol Chem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1126\/science.1325670","article-title":"The cloning of a family of genes that encode the melanocortin receptors","volume":"257","author":"Mountjoy","year":"1992","journal-title":"Science"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1210\/endo.132.6.8389287","article-title":"Modulation of aldosterone synthase messenger ribonucleic acid levels by dietary sodium and potassium and by adrenocorticotropin","volume":"132","author":"Holland","year":"1993","journal-title":"Endocrinology"},{"key":"B33","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1530\/acta.0.0950198","article-title":"The effect of chronic low-dose infusion of ACTH (1-24) on renin, renin-substrate, aldosterone and other corticosteroids in sodium replete and deplete man","volume":"95","author":"Fuchs-Hammoser","year":"1980","journal-title":"Acta Endocrinol (Copenh)"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1080\/07435809609043729","article-title":"Regulation of adrenal steroidogenesis during chronic stress","volume":"22","author":"Aguilera","year":"1996","journal-title":"Endocr Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9258(20)64320-4","article-title":"ACTH-induced inhibition of the action of angiotensin II in bovine zona glomerulosa cells. A modulatory effect of cyclic AMP on the angiotensin II receptor","volume":"266","author":"Yoshida","year":"1991","journal-title":"J Biol Chem"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1210\/endo.134.6.8194473","article-title":"Regulation of type 1 angiotensin II receptor messenger ribonucleic acid expression in human adrenocortical carcinoma H295 cells","volume":"134","author":"Bird","year":"1994","journal-title":"Endocrinology"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1210\/endo-122-5-2012","article-title":"Dual regulation of 3 beta-hydroxysteroid dehydrogenase, 17 alpha-hydroxylase, and dehydroepiandrosterone sulfotransferase by adenosine 3\u2019,5\u2019-monophosphate and activators of protein kinase C in cultured human adrenocortical cells","volume":"122","author":"McAllister","year":"1988","journal-title":"Endocrinology"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.81.6.8964847","article-title":"Differential control of 17 alpha-hydroxylase and 3 beta-hydroxysteroid dehydrogenase expression in human adrenocortical H295R cells","volume":"81","author":"Bird","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"B39","article-title":"Challenges with luteinizing hormone-releasing hormone agonists: flare and surge","author":"Brawer","year":"2004","journal-title":"Rev Urol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqad046","article-title":"Sublethal hyperthermia transiently disrupts cortisol steroidogenesis in adrenocortical cells","volume":"164","author":"Mullen","year":"2023","journal-title":"Endocrinology"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1472","article-title":"Study heterogeneity and estimation of prevalence of primary aldosteronism: A systematic review and meta-regression analysis","volume":"101","author":"K\u00e4yser","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1097\/MED.0000000000000408","article-title":"Primary aldosteronism in the primary care setting","volume":"25","author":"Buffolo","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.51438","article-title":"Detecting primary aldosteronism in Australian primary care: a prospective study","volume":"216","author":"Libianto","year":"2022","journal-title":"Med J Aust"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1152\/physrev.00026.2015","article-title":"Primary aldosteronism: changing definitions and new concepts of physiology and pathophysiology both inside and outside the kidney","volume":"96","author":"Stowasser","year":"2016","journal-title":"Physiol Rev"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-010-0134-2","article-title":"Prevalence and diagnosis of primary aldosteronism","volume":"12","author":"Rossi","year":"2010","journal-title":"Curr Hypertens Rep"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/s41574-020-0382-4","article-title":"Pathogenesis and treatment of primary aldosteronism","volume":"16","author":"Zennaro","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-024-02908-1","article-title":"The renin angiotensin aldosterone system","volume":"476","author":"Triebel","year":"2024","journal-title":"Pflugers Arch"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.118.033597","article-title":"Primary aldosteronism: practical approach to diagnosis and management","volume":"138","author":"Byrd","year":"2018","journal-title":"Circulation"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-0681","article-title":"Evidence for abnormal left ventricular structure and function in normotensive individuals with familial hyperaldosteronism type I","volume":"90","author":"Stowasser","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaf284","article-title":"Primary aldosteronism: an endocrine society clinical practice guideline","volume":"110","author":"Adler","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"B56","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13463","article-title":"Clinical outcomes of 1625 patients with primary aldosteronism subtyped with adrenal vein sampling","volume":"74","author":"Rossi","year":"2019","journal-title":"Hypertension"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0000000000003200","article-title":"The primary aldosteronism surgical outcome score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism","volume":"272","author":"Burrello","year":"2020","journal-title":"Ann Surg"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-017-4311-1","article-title":"Refining the definitions of biochemical and clinical cure for primary aldosteronism using the primary aldosteronism surgical outcome (PASO) classification system","volume":"42","author":"Miller","year":"2018","journal-title":"World J Surg"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.1210\/endrev\/bnad026","article-title":"Treating primary aldosteronism-induced hypertension: novel approaches and future outlooks","volume":"45","author":"Mullen","year":"2024","journal-title":"Endocr Rev"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(24)00308-5","article-title":"Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort","volume":"13","author":"Yang","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2004.06.051","article-title":"Role for adrenal venous sampling in primary aldosteronism","volume":"136","author":"Young","year":"2004","journal-title":"Surgery"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.11086","article-title":"Cellular and genetic causes of idiopathic hyperaldosteronism","volume":"72","author":"Omata","year":"2018","journal-title":"Hypertension"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat Genet"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat Genet"},{"key":"B69","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat Genet"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2007.03033.x","article-title":"Frequent mutations of beta-catenin gene in sporadic secreting adrenocortical adenomas","volume":"68","author":"Tadjine","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504869","article-title":"Pregnancy, primary aldosteronism, and adrenal CTNNB1 mutations","volume":"373","author":"Teo","year":"2015","journal-title":"N Engl J Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0053-8","article-title":"A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism","volume":"50","author":"Fernandes-Rosa","year":"2018","journal-title":"Nat Genet"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14349","article-title":"Somatic CACNA1H mutation as a cause of aldosterone-producing adenoma","volume":"75","author":"Nanba","year":"2020","journal-title":"Hypertension"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-021-00906-y","article-title":"Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause","volume":"53","author":"Zhou","year":"2021","journal-title":"Nat Genet"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01403-0","article-title":"Somatic mutations of CADM1 in aldosterone-producing adenomas and gap junction-dependent regulation of aldosterone production","volume":"55","author":"Wu","year":"2023","journal-title":"Nat Genet"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-023-01498-5","article-title":"Somatic SLC30A1 mutations altering zinc transporter ZnT1 cause aldosterone-producing adenomas and primary aldosteronism","volume":"55","author":"Rege","year":"2023","journal-title":"Nat Genet"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.125.24909","article-title":"Somatic mutations in MCOLN3 are associated with aldosterone-producing adenomas","volume":"82","author":"van Rooyen","year":"2025","journal-title":"Hypertension"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"B80","doi-asserted-by":"publisher","first-page":"R1","DOI":"10.1530\/EJE-21-0031","article-title":"GENETICS IN ENDOCRINOLOGY: Impact of race and sex on genetic causes of aldosterone-producing adenomas","volume":"185","author":"Nanba","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"B81","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.tem.2021.10.002","article-title":"Pathophysiology and histopathology of primary aldosteronism","volume":"33","author":"Williams","year":"2022","journal-title":"Trends Endocrinol Metab"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic characteristics of aldosterone-producing adenomas in blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension"},{"key":"B83","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1210\/jc.2015-3284","article-title":"Clinical and steroidogenic characteristics of aldosterone-producing adenomas with ATPase or CACNA1D gene mutations","volume":"101","author":"Kitamoto","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.3803\/EnM.2017.32.3.332","article-title":"CTNNB1 mutation in aldosterone producing adenoma","volume":"32","author":"Wang","year":"2017","journal-title":"Endocrinol Metab (Seoul)"},{"key":"B85","doi-asserted-by":"publisher","first-page":"K37","DOI":"10.1530\/EJE-19-0377","article-title":"A somatic mutation in CLCN2 identified in a sporadic aldosterone-producing adenoma","volume":"181","author":"Dutta","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"B86","doi-asserted-by":"publisher","first-page":"bvaa123","DOI":"10.1210\/jendso\/bvaa123","article-title":"Identification of somatic mutations in CLCN2 in aldosterone-producing adenomas","volume":"4","author":"Rege","year":"2020","journal-title":"J Endocr Soc"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.02234","article-title":"Role for germline mutations and a rare coding single nucleotide polymorphism within the KCNJ5 potassium channel in a large cohort of sporadic cases of primary aldosteronism","volume":"63","author":"Murthy","year":"2014","journal-title":"Hypertension"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1016\/j.ebiom.2016.10.002","article-title":"CACNA1H mutations are associated with different forms of primary aldosteronism","volume":"13","author":"Daniil","year":"2016","journal-title":"EBioMedicine"},{"key":"B89","doi-asserted-by":"publisher","first-page":"G1","DOI":"10.1093\/ejendo\/lvae041","article-title":"Familial hyperaldosteronism: an European Reference Network on Rare Endocrine Conditions clinical practice guideline","volume":"190","author":"Mulatero","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1038\/355262a0","article-title":"A chimaeric 11 beta-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1210\/jc.85.6.2160","article-title":"Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance","volume":"85","author":"Stowasser","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8529(18)30098-7","article-title":"Glucocorticoid-remediable aldosteronism","volume":"23","author":"Dluhy","year":"1994","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1046\/j.1440-1681.2001.03574.x","article-title":"Familial varieties of primary aldosteronism","volume":"28","author":"Stowasser","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"B94","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1161\/HYPERTENSIONAHA.111.175083","article-title":"Prevalence and characteristics of familial hyperaldosteronism: the PATOGEN study (Primary Aldosteronism in TOrino-GENetic forms)","volume":"58","author":"Mulatero","year":"2011","journal-title":"Hypertension"},{"key":"B95","doi-asserted-by":"publisher","DOI":"10.1136\/jmg.37.11.831","article-title":"A novel genetic locus for low renin hypertension: familial hyperaldosteronism type II maps to chromosome 7 (7p22)","volume":"37","author":"Lafferty","year":"2000","journal-title":"J Med Genet"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 chloride channel mutations in familial hyperaldosteronism type II","volume":"50","author":"Scholl","year":"2018","journal-title":"Nat Genet"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B98","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human mendelian hypertension featuring nonglucocorticoid-remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"B99","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mce.2016.10.025","article-title":"Disordered zonal and cellular CYP11B2 enzyme expression in familial hyperaldosteronism type 3","volume":"439","author":"Gomez-Sanchez","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"e06315","DOI":"10.7554\/eLife.06315.019","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"Elife"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10607","article-title":"Association between genetic variation of CACNA1H and childhood absence epilepsy","volume":"54","author":"Chen","year":"2003","journal-title":"Ann Neurol"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M603316200","article-title":"CACNA1H mutations in autism spectrum disorders","volume":"281","author":"Splawski","year":"2006","journal-title":"J Biol Chem"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-015-1776-3","article-title":"Two heterozygous Cav3.2 channel mutations in a pediatric chronic pain patient: recording condition-dependent biophysical effects","volume":"468","author":"Souza","year":"2016","journal-title":"Pflugers Arch"},{"key":"B104","doi-asserted-by":"publisher","DOI":"10.1530\/EJE-17-0946","article-title":"GENETICS IN ENDOCRINOLOGY: The expanding genetic horizon of primary aldosteronism","volume":"178","author":"Monticone","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"B105","article-title":"Adrenocortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French Association of Endocrine Surgery","volume":"112","author":"Icard","year":"1992","journal-title":"Surgery"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.1159\/000227608","article-title":"Adrenocortical carcinoma: experience in 45 patients","volume":"54","author":"Barzon","year":"2009","journal-title":"Oncology"},{"key":"B107","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s003450050101","article-title":"Adrenocortical carcinoma","volume":"17","author":"Schulick","year":"1999","journal-title":"World J Urol"},{"key":"B108","doi-asserted-by":"publisher","DOI":"10.1677\/erc.1.00867","article-title":"Aldosterone-producing adrenocortical carcinoma: an unusual cause of Conn\u2019s syndrome with an ominous clinical course","volume":"12","author":"Seccia","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvab048.2014","article-title":"A case of aldosterone producing adrenocortical carcinoma","volume":"5","author":"Soe","year":"2021","journal-title":"J Endocrine Soc"},{"key":"B110","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1507\/endocrj.EJ16-0243","article-title":"Characteristics of Japanese aldosterone-producing adenomas with KCNJ5 mutations","volume":"64","author":"Okamura","year":"2017","journal-title":"Endocr J"},{"key":"B111","doi-asserted-by":"publisher","first-page":"e708","DOI":"10.1097\/MD.0000000000000708","article-title":"Prevalence and characterization of somatic mutations in Chinese aldosterone-producing adenoma patients","volume":"94","author":"Wang","year":"2015","journal-title":"Med (Baltimore)"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1210\/js.2018-00097","article-title":"Prevalence of somatic KCNJ5 mutations in thai patients with aldosterone-producing adrenal adenomas","volume":"2","author":"Warachit","year":"2018","journal-title":"J Endocr Soc"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14177","article-title":"Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma","volume":"75","author":"De Sousa","year":"2020","journal-title":"Hypertension"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.113.01733","article-title":"Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas","volume":"63","author":"Williams","year":"2014","journal-title":"Hypertension"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.1093\/emboj\/16.7.1582","article-title":"Molecular dissection of gating in the ClC-2 chloride channel","volume":"16","author":"Jordt","year":"1997","journal-title":"EMBO J"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1038\/360759a0","article-title":"Regions involved in the opening of CIC-2 chloride channel by voltage and cell volume","volume":"360","author":"Gr\u00fcnder","year":"1992","journal-title":"Nature"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.215","article-title":"Molecular basis for the tissue specificity of \u03b2-catenin oncogenesis","volume":"32","author":"Sharma","year":"2013","journal-title":"Oncogene"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/\u03b2-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1210\/en.2002-220275","article-title":"Wnt-4 deficiency alters mouse adrenal cortex function, reducing aldosterone production","volume":"143","author":"Heikkil\u00e4","year":"2002","journal-title":"Endocrinology"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.1242\/dev.021493","article-title":"Targeted disruption of beta-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex","volume":"135","author":"Kim","year":"2008","journal-title":"Development"},{"key":"B121","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1038\/nrg1427","article-title":"WNT and beta-catenin signalling: diseases and therapies","volume":"5","author":"Moon","year":"2004","journal-title":"Nat Rev Genet"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1387\/ijdb.041815jb","article-title":"The Wnt connection to tumorigenesis","volume":"48","author":"Behrens","year":"2004","journal-title":"Int J Dev Biol"},{"key":"B123","doi-asserted-by":"publisher","DOI":"10.1111\/cen.12873","article-title":"Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype","volume":"83","author":"Scholl","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B124","doi-asserted-by":"publisher","first-page":"19546","DOI":"10.1038\/srep19546","article-title":"Activating mutations in CTNNB1 in aldosterone producing adenomas","volume":"6","author":"\u00c5kerstr\u00f6m","year":"2016","journal-title":"Sci Rep"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.lpm.2018.07.006","article-title":"Molecular genetics of Conn adenomas in the era of exome analysis","volume":"47","author":"El Zein","year":"2018","journal-title":"Presse Med"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2014.01.016","article-title":"Aberrant gonadotropin-releasing hormone receptor (GnRHR) expression and its regulation of CYP11B2 expression and aldosterone production in adrenal aldosterone-producing adenoma (APA)","volume":"384","author":"Nakamura","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1055\/s-0033-1358733","article-title":"LH, progesterone, and TSH can stimulate aldosterone in vitro: a study on normal adrenal cortex and aldosterone producing adenoma","volume":"46","author":"Nicolini","year":"2014","journal-title":"Horm Metab Res"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.110.158543","article-title":"Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism","volume":"56","author":"Boulkroun","year":"2010","journal-title":"Hypertension"},{"key":"B129","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1210\/jc.2015-3285","article-title":"Case report: nodule development from subcapsular aldosterone-producing cell clusters causes hyperaldosteronism","volume":"101","author":"Nishimoto","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1874","article-title":"Aldosterone-producing adenoma with a somatic KCNJ5 mutation revealing APC-dependent familial adenomatous polyposis","volume":"101","author":"Vouillarmet","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13476","article-title":"Primary aldosteronism: KCNJ5 mutations and adrenocortical cell growth","volume":"74","author":"Yang","year":"2019","journal-title":"Hypertension"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-2149","article-title":"A meta-analysis of somatic KCNJ5 K(+) channel mutations in 1636 patients with an aldosterone-producing adenoma","volume":"100","author":"Lenzini","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical characteristics of somatic mutations in Chinese patients with aldosterone-producing adenoma","volume":"65","author":"Zheng","year":"2015","journal-title":"Hypertension"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2016.07.031","article-title":"Somatic KCNJ5 mutation occurring early in adrenal development may cause a novel form of juvenile primary aldosteronism","volume":"441","author":"Tamura","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"B135","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpz172","article-title":"Mosaicism for KCNJ5 causing early-onset primary aldosteronism due to bilateral adrenocortical hyperplasia","volume":"33","author":"Maria","year":"2020","journal-title":"Am J Hypertens"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1736534\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,12]],"date-time":"2026-01-12T05:44:46Z","timestamp":1768196686000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2025.1736534\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,12]]},"references-count":135,"alternative-id":["10.3389\/fendo.2025.1736534"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2025.1736534","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,12]]},"article-number":"1736534"}}